Global Vaccines Market 2020 By Technology [Conjugate vaccines, Inactivated and subunit vaccines, Live attenuated vaccines, Recombinant vaccines, Toxoid vaccines and others],By Type [Monovalent vaccines, Multivalent vaccines and others], By Patient Type[Pediatric patients, Adult patients and others], By Disease[Cancer, Dengue, DTP, Hepatitis, Human Papilloma Virus, Influenza, Meningococcal Disease, Pneumococcal disease, Polio, Rotavirus and others]: Global Forecast to 2026 and COVID-19 Impact Outlook Global Vaccines Market is valued at USD 45.9 Billion in 2019 and expected to reach USD 91.9 Billion by 2026 with the CAGR of 10.44 % over the forecast period.

1. Global Vaccines Market 2020 By Technology [Conjugate vaccines, Inactivated and subunit
vaccines, Live attenuated vaccines, Recombinant vaccines, Toxoid vaccines and others],By Type
[Monovalentvaccines, Multivalent vaccines and others], By Patient Type[Pediatric patients, Adult
patients and others], By Disease[Cancer, Dengue, DTP, Hepatitis, Human Papilloma Virus,
Influenza, Meningococcal Disease, Pneumococcal disease, Polio, Rotavirus and others]: Global
Forecast to 2026 and COVID-19 Impact Outlook
Global Vaccines Market is valued at USD 45.9 Billion in 2019 and expected to reach USD 91.9
Billion by 2026 with the CAGR of 10.44 % over the forecast period.
Scope of the report
A vaccine isa biological preparationthatprovidesimmunityagainstdisease. Vaccinesare besthealth
interventionsavailable todaytopreventinfectiousdiseases such as influenza, measles, mumps and
other.Widespread use of vaccines has resulted in considerable progress against some of the most
devastating human diseases. Many new approaches are being adopted in development of vaccine
such as DNA vaccines, Peptide vaccines which could help in faster antigen detection and induce
effectiveimmuneresponse.Furtheradvancementinvaccine preservationtechniques, drug delivery
systems will facilitate growth in forecast period.
This report analyses the global market for Vaccines. The report will enable the user to understand
and gain insights into the current and forecast market situation. The market is comprehensively
analyzed by geography to give complete information on the global scenario. The qualitative and
quantitative dataprovided in this study can help user understand which market segments, regions
are expected to grow at higher rates, factors affecting the market and key opportunity areas. The
reportalsoincludescompetitivelandscapeof keyplayersinthe industryalongwithemerging trends
in the market.
Key Players
1. Abbott Laboratories Inc.
2. AstraZeneca Plc
3. CSL Ltd.
4. Emergent BioSolutions Inc.
5. GlaxoSmithKline Plc.
6. Janssen Pharmaceuticals Inc.
7. Johnson and Johnson

2. 8. Merck &Co. Inc.
9. Novartis AG
10. Pfizer Inc.
11. Sanofi Pasteur Inc.
12. Takeda Pharmaceuticals Company Ltd.
13. Valeant Pharmaceuticals International Inc.
14. others
Above mentioned companies were scrutinized to assess competitive landscape of global Vaccines
market. Report provides company profiles of each player. Each profile include company product
portfolio,business overview, company governance, company financials, business strategies,
manufacturinglocationsandproductionfacilities,companysale,recentdevelopments and strategic
collaborations &partnerships, newproductlaunch, company segments, application diversification
and company strength and weakness analysis.
Review period:(2016-2026)
Historic Period:2016 to 2019
Forecast Period:2020 to 2026
Base Year: 2019
Unit:USD Billion
This Vaccines market report provides insights on new trade regulations, import export analysis,
industryvalue chainanalysis, marketsize, consumption, production analysis, regional and segment
marketshare,productlaunches,product pipeline analysis, impact of Covid-19 on supply chain, key
regions, untapped markets, patent analysis, product approvals, continuous innovations and
developments in the market.
Regions
 North America: U.S.,Canada and Restof North America
 Europe: UK, France,Germany,Italy,SpainandRestof Europe
 Asia Pacific:China,Japan,India,Australia, SoutheastAsiaandRestof AsiaPacific
 Latin America: Brazil, Mexico, ArgentinaandRestof LatinAmerica
 Middle East and Africa: Gulf Countries,Israel,AfricaandRestof Middle Eastand Africa
Regional Insights

3. NorthAmericadominatesthe global vaccine market. The growth in the region was primarily driven
by presence of advanced healthcare infrastructure, prevalence of infectious diseases, key players
with robust research and development capabilities and growing private and government capital
investments for the development of vaccines. Asia Pacific is the fastest growing market which
recordedhighestCAGRin2019. Proactive measuresof government to tackle the growing infectious
diseases,investmentsondevelopment of healthcare infrastructure, rising prevalence of infectious
diseases are some driving the growth of vaccine market in this region. Further developing
biopharmaceutical sectorhasbroughtsignificantgrowthopportunities.The regionhaslarge number
of vaccine manufacturersofferinglow costproductionsolutions for licenced vaccine manufacturers
and has seen unprecedented growth in vaccine development. The manufacturers are providing
market with innovative products such as cholera vaccines, hepatitis A vaccines, typhoid
glycoconjugate vaccine,rotavirusvaccinesetc.Risinginvestmentsin COVID 19 vaccine production is
expectedtoofferlucrativegrowthopportunities in future. For instance Chinese biopharmaceutical
products company Sinovac Biotech has received $15m funding to advance the development of its
CoronaVac Covid-19 vaccine.
Global Vaccines Market Dynamics
Progress has already been made with several therapeutic vaccines for cancer, diabetes,
hypertension and Alzheimer's disease. According to the WHO (World Health Organization) in 2019
were more than 240 vaccines in development for 25 infectious diseases. HIV/AIDS, malaria,
pneumococcal infections, tuberculosis, and Ebola vaccine are the major diseases leading the way.
Increasingcompanyinitiatives to enhance vaccine R&D, growing prevalence of infectious diseases
and exploding population growth are the major drivers for the growth of global vaccine market. In
addition to this spread of novel coronavirus around the world has resulted into fast track vaccine
developmenttocontrol the disease. There are 321 candidates in coronavirus vaccine development
as of October2020. Out of which 44 vaccine candidateswere conductingclinical trials 34 in Phase I–
II trialsand10 inPhase II–IIItrial.Stringentregulatorypolicies,complexity of vaccine development,
longer clinical trials are factors hampering the growth of global market. Growing investments and
on-going research on vaccine developments are expected to foster the market growth in forecast
period.
Market Segmentation
 Technology
o Conjugate vaccines
o Inactivatedandsubunitvaccines

4. o Live attenuatedvaccines
o Recombinantvaccines
o Toxoidvaccines
 Type
o Monovalentvaccines
o Multivalentvaccines
 PatientType
o Pediatricpatients
o Adultpatients
 Disease
o Cancer
o Dengue
o DTP
o Hepatitis
o Human PapillomaVirus
o Influenza
o Meningococcal Disease
o Pneumococcal disease
o Polio
o Rotavirus
Report Coverage
 An overview of the global Vaccines market
 In depth analysis of market dynamics and major factors such as drivers, restraints,
opportunities and trends influencing the global market
 Global Vaccines market revenue data historic and forecast analysis (2016 to 2026)
 Characterization and quantification of the market segments for Vaccines market
 Market share analysis of key market participants and their competitive landscape
Important Questions Answered by Global Vaccines Market Report
 What is the impact of COVID 19 epidemic on the global Vaccines market?
 Which is mostly affected region, country?
 Which is the current largest and fastest-growing region?
 What is the market size and growth rate of the global Vaccines market?
 What are current factors affecting the growth of market?
 What are Key trends and opportunity areas?
 WithinVaccines market,which segments are fastest growing & emerging strongly?
What are the drivers and restraints for each segment? What are vendor
competencies by segment?

5.  What are the major strategies adopted by leading market companies?
 What are company challenges and essential success factors by market segment?
 How company offeringsand supplychaincapabilities are shifting to meet emerging
market needs?

6. Table of Content
1. Introduction
1.1. Report Description
1.2. Market Segmentation
1.3. Research Methodology
1.4. List of Abbreviations
2. Executive Summary
3. Market Overview
3.1. Market Definition
3.2. Market Scope
3.3. Market Drivers
3.4. Market Restraints
3.5. Market Opportunities and Trends
3.6. Porter’s five force analysis
3.7. SWOT Analysis
3.8. PEST Analysis
3.9. Patent Analysis
3.10. Impact of COVID 19 on Global Vaccines Market
4. Vaccines Market, By Technology, Market Size, Consumption and
Forecast 2016 -2026 (USD Billion)
4.1. Global Vaccines Market By Technology, 2016 -2026 (USD Billion)
4.1.1. Global Vaccines Market By Conjugate vaccines
4.1.2. Global Vaccines Market By Inactivated and subunit vaccines
4.1.3. Global Vaccines Market By Live attenuated vaccines
4.1.4. Global Vaccines Market By Recombinant vaccines
4.1.5. Global Vaccines Market By Toxoid vaccines
4.2. Global Vaccines Market By Technology Share, 2016 -2026 (%)
5. Vaccines Market, By Patient Type, Market Size, Consumption and
Forecast 2016 -2026 (USD Billion)
5.1. Global Vaccines Market By Patient Type, 2016 -2026 (USD Billion)
5.1.1. Global Vaccines Market By Pediatric patients
5.1.2. Global Vaccines Market By Adult patients
5.2. Global Vaccines Market By Patient Type Share, 2016 -2026 (%)
6. Vaccines Market, By Type, Market Size, Consumption and Forecast
2016 -2026 (USD Billion)

7. 6.1. Global Vaccines Market By Type, 2016 -2026 (USD Billion)
6.1.1. Global Vaccines Market By Monovalent vaccines
6.1.2. Global Vaccines Market By Multivalent vaccines
6.2. Global Vaccines Market By Type Share, 2016 -2026 (%)
7. Vaccines Market, By Disease, Market Size, Consumption and Forecast
2016 -2026 (USD Billion)
7.1. Global Vaccines Market By Disease, 2016 -2026 (USD Billion)
7.1.1. Global Vaccines Market By Cancer
7.1.2. Global Vaccines Market By Dengue
7.1.3. Global Vaccines Market By DTP
7.1.4. Global Vaccines Market By Hepatitis
7.1.5. Global Vaccines Market By Human Papilloma Virus
7.1.6. Global Vaccines Market By Influenza
7.1.7. Global Vaccines Market By Meningococcal Disease
7.1.8. Global Vaccines Market By Pneumococcaldisease
7.1.9. Global Vaccines Market By Polio
7.1.10. Global Vaccines Market By Rotavirus
7.2. Global Vaccines Market By Disease Share, 2016 -2026 (%)
8. Vaccines Market, By Region Market Size, Consumption and Forecast
2016 -2026
8.1. NORTH AMERICA
8.1.1. Key Findings
8.1.2. Impact of COVID 19
8.1.3. Key market trends, growth factors and opportunities
8.1.4. North America Vaccines Market by Country 2016 -2026 (USD
Billion)
8.1.5. North America Vaccines Market By Technology 2016 -2026 (USD
Billion)
8.1.6. North America Vaccines Market By Type 2016 -2026 (USD Billion)
8.1.7. North America Vaccines Market By Patient Type 2016 -2026 (USD
Billion)
8.1.8. North America Vaccines Market By Disease 2016 -2026 (USD
Billion)
8.2. EUROPE
8.2.1. Key Findings

8. 8.2.2. Impact of COVID 19
8.2.3. Key market trends, growth factors and opportunities
8.2.4. Europe Vaccines Market by Country 2016 -2026 (USD Billion)
8.2.5. Europe Vaccines Market By Technology 2016 -2026 (USD Billion)
8.2.6. Europe Vaccines Market By Type 2016 -2026 (USD Billion)
8.2.7. Europe Vaccines Market By Patient Type 2016 -2026 (USD Billion)
8.2.8. Europe Vaccines Market By Disease 2016 -2026 (USD Billion)
8.3. ASIA PACIFIC
8.3.1. Key Findings
8.3.2. Impact of COVID 19
8.3.3. Key market trends, growth factors and opportunities
8.3.4. Asia Pacific Vaccines Market by Country 2016 -2026 (USD Billion)
8.3.5. Asia Pacific Vaccines Market By Technology 2016 -2026 (USD
Billion)
8.3.6. Asia Pacific Vaccines Market By Type 2016 -2026 (USD Billion)
8.3.7. Asia Pacific Vaccines Market By Patient Type 2016 -2026 (USD
Billion)
8.3.8. Asia Pacific Vaccines Market By Disease 2016 -2026 (USD Billion)
8.4. LATIN AMERICA
8.4.1. Key Findings
8.4.2. Impact of COVID 19
8.4.3. Key market trends, growth factors and opportunities
8.4.4. Latin America Vaccines Market by Country 2016 -2026 (USD Billion)
8.4.5. Latin America Vaccines Market By Technology 2016 -2026 (USD
Billion)
8.4.6. Latin America Vaccines Market By Type 2016 -2026 (USD Billion)
8.4.7. Latin America Vaccines Market By Patient Type 2016 -2026 (USD
Billion)
8.4.8. Latin America Vaccines Market By Disease 2016 -2026 (USD Billion)
8.5. MIDDLE EAST AND AFRICA
8.5.1. Key Findings
8.5.2. Impact of COVID 19
8.5.3. Key market trends, growth factors and opportunities
8.5.4. Middle East and Africa Vaccines Market by Country 2016 -2026
(USD Billion)

9. 8.5.5. Middle East and Africa Vaccines Market By Technology 2016 -2026
(USD Billion)
8.5.6. Middle East and Africa Vaccines Market By Type 2016 -2026 (USD
Billion)
8.5.7. Middle East and Africa Vaccines Market By Patient Type 2016 -2026
(USD Billion)
8.5.8. Middle East and Africa Vaccines Market By Disease 2016 -2026
(USD Billion)
9. Competitive Landscape Analysis
9.1. Global Vaccines Market Company Revenue, (USD Billion), 2016-
2019
9.2. Global Vaccines Market Company Share, (%), 2016-2019
10. Global Vaccines Market Price Analysis
10.1. Global Vaccines Market Price By Regions
11. Global Vaccines Market Value Chain Analysis
12. Company Profiles
12.1. Abbott Laboratories, Inc.
12.2. AstraZeneca Plc
12.3. CSL Ltd.
12.4. Emergent BioSolutions, Inc.
12.5. GlaxoSmithKline Plc.
12.6. Janssen Pharmaceuticals, Inc.
12.7. Johnson and Johnson
12.8. Merck &Co., Inc.
12.9. Novartis AG
12.10. Pfizer, Inc.
12.11. Sanofi Pasteur, Inc.
12.12. Takeda Pharmaceuticals Company Ltd.
12.13. Valeant Pharmaceuticals International, Inc.
12.14. Others
13. Appendix
14. List of Tables
15. List of Figures